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A R T I C L E
Handling adverse drug reactions: state 
influence on access and availability of 
medicines in the former German 
Democratic Republic (GDR), 1949 to 1990
Ariane Retzar
Abstract
In the former German Democratic Republic, state in-
stitutions that controlled the supply of medicinal prod-
ucts were already established in the late 1940s and the 
early 1950s . These included Zentraler Gutachterauss-
chuss für Arzneimittelverkehr (Central Review Com-
mittee for Drug Supply) and Institut für Arzneimittel-
wesen (Institute for Drugs) . Both were involved in the 
assessment of adverse drug reactions . A reporting form 
was published in 1969 . However, the number of reports 
was low, so developments in other countries such as the 
Federal Republic of Germany had to be considered . Us-
ing selected examples this article illustrates the actions 
that were taken to avoid damage caused by drugs, and 
shows that decisions were taken not only for medical 
reasons but also for economic and political ones . Ensur-
ing adequate supply of drugs also had to be considered .
Zusammenfassung
Bereits Ende der 1940er- und Anfang der 1950er-Jahre 
wurden in der DDR staatliche Institutionen geschaffen, 
um den Arzneimittelverkehr zu überwachen . Hierzu 
gehörten der Zentrale Gutachterausschuss für Arznei-
mittelverkehr (ZGA) und das Institut für Arzneimit-
telwesen (IfAr) . Der ZGA und das IfAr waren auch an 
der Erfassung und Bewertung von unerwünschten Arz-
neimittelwirkungen beteiligt . Ein Meldeformular wur-
de 1969 veröffentlicht . Aufgrund der geringen Melde-
zahl musste jedoch häufig die Entwicklung in anderen 
Ländern wie etwa der Bundesrepublik berücksichtigt 
werden . Anhand ausgewählter Beispiele untersucht der 
Aufsatz, welche Maßnahmen ergriffen wurden, um 
Arzneimittelrisiken abzuwehren . Dabei spielten jedoch 
nicht nur medizinische, sondern auch wirtschaftliche, 
politische und versorgungstechnische Aspekte eine Rol-
le .
Introduction
It was in 1949, precisely one day before the German 
Democratic Republic (East Germany) was founded on 
7 October, that a regulation came into effect in the So-
viet occupation zone controlling the distribution of me-
dicinal products . From that date drugs had to be regis-
tered with the state . 
A special committee called Zentraler Gutachterauss-
chuss für Arzneimittelverkehr (ZGA) (the Central Re-
view Committee for Drug Supply) advised the Ministry 
of Health on the registration or deletion of drugs .1 
From 1964 the ZGA also had to give its agreement be-
fore clinical trials could be conducted .2 Members of the 
ZGA were clinicians, pharmacologists, pharmacists, 
medical practitioners, dentists and also representatives 
from industry . From 1960 sub-committees were cre-
ated to discuss particular problems, for example those 
concerned with the supply of antidiabetic drugs . To co-
ordinate the activities of the committee a secretariat was 
established; this has been situated in the state Institut 
für Arzneimittelwesen (IfAr) in Berlin since 1956 .3
The IfAr, first established in 1950, also had to fulfil 
several other functions . For instance, the institute was 
responsible for the publication of the drug index and 
the revision of the pharmacopeia . The institute was also 
involved in the quality control of drug products manu-
factured by the pharmaceutical industry, and it also 
took charge of collecting reports of adverse drug reac-
tions (ADRs) .4
The adverse drug reactions reporting form 1969
For this purpose a special form was provided in the 
drug index since 1969 (Figure 1) .5 It contained infor-
mation about age, sex, diseases and the administered 
drugs . At the end, doctors were requested to assess 
which drug might have caused the observed adverse re-
action .6 These measures were intended to make an im-
portant contribution towards increasing drug safety . 
For instance, it was stated that special recommenda-
tions with regard to drug therapy should be made based 
on incoming reports . In addition, a stimulus for drug 
development was expected .7
Figure 1: Reporting form published in 1969
The reporting form published in 1969 was revised 
twice: from 1980 the severity of adverse reactions had 
to be assessed, and therapeutic measures had to be ex-
 PHARMACEUTICAL HISTORIAN  ·  2017  ·  Volume 47/4 75
https://doi.org/10.24355/dbbs.084-202007291108-0
plained . More details about the medication were re-
quired, such as the dosage and the duration of applica-
tion . Allergies had to be mentioned as well .8 From 1986 
doctors had to assess whether a causal relationship ex-
isted between the administration of a drug and an ad-
verse reaction . In this context, for example, the devia-
tion of laboratory parameters was relevant .9 Since that 
time, forms were no longer published in the drug index, 
but were provided by pharmacists .10 
Between 1969 and 1970 the number of annual re-
ports increased from 47 to 160, and there was a steady 
increase after that, but on average between 1969 and 
1989 the IfAr did not receive more than 335 reports 
each year (Figure 2) .11
and pharmaceutical journals such as Das deutsche Ge-
sundheitswesen15 and Medicamentum16, the last of which 
was edited by the pharmaceutical industry . The impor-
tance of reporting adverse reactions was also empha-
sized in central recommendations for therapy,17 edited 
by the IfAr on behalf of the Ministry of Health . These 
recommendations served as guidelines for the diagnosis 
and therapy of diseases such as diabetes . They were 
written by experts in accordance with the medical as-
sociations .18 In August 1975 the Minister of Health, 
Ludwig Mecklinger (1919-1994), also demanded that 
all incidents caused by drugs be reported to the IfAr .19
In 1981 a directive came into effect regulating the 
storage and prescription of drugs . According to this di-
rective adverse reactions had to be reported if they were 
unusual, required therapeutic measures, or a prolonged 
stay in hospital .20 Adverse reactions were characterized 
as unusual if they were not listed in the current edition 
of the Taschenbuch Arzneimittelsicherheit,21 a reference 
book in the field of drug safety containing information 
not only about adverse reactions but also about interac-
tions, contra-indications and dosage . It was first re-
leased in 1983 and revised in 1986 .22
Head lice products in the 1980s
Although doctors were requested to report ADRs in the 
1970s, and although an obligation for them to do so 
was introduced in 1981 (and was later enshrined in the 
drug law of 1986)23 the number of reports hardly in-
creased until 1990 . Only in one case, namely that of 
the anti-pediculotic preparation Arupex® which con-
tained lindane (gamma-hexachlorocyclohexane), did 
accounts of adverse reactions lead to a modified benefit-
risk assessment .24 In the GDR products containing lin-
dane, which were used against head lice, were available 
since 1969 . The range included Delitex® Shampoo and 
Delitex® liquidum, the last of which contained 0 .5 per 
cent of lindane in benzine, paraffin and propanol .25
Due to its flammability the adjuvants were replaced 
by isopropanol and propylene glycol and the lindane 
content was increased up to one per cent . In order to 
clarify the altered formulation, the product, now la-





































Figure 2: Number of reports between 1969 and 1989
Table 1 illustrates the number of reports compared 
to other countries . In Sweden 3,000 reports were re-
ceived each year, which corresponded to 361 reports per 
million inhabitants . In the Federal Republic of Ger-
many the number of reports amounted to 68 per mil-
lion, and in the United Kingdom to 236 reports per 
million .12 
Amongst the members of the Council for Mutual 
Economic Assistance, Czechoslovakia was the most 
successful country in generating adverse drug reaction 
reports . In that country adverse drug reactions had 
been reported since 1964 . Czechoslovakia also partici-
pated as one of the first countries in the monitoring 
programme set up by the World Health Organization 
in 1968 .13 In addition, the country had coordinated the 
collection of reports of adverse reactions within the 
Council for Mutual Economic Assistance since 1979 . 
The GDR had forwarded reports to the monitoring cen-
tre in Prague since 1982 . However, the cooperation be-
tween the countries was assessed as ineffective .14
Initiatives designed to increase the reporting of 
ADRs in the 1970s and 1980s
In order to increase the number of reports in the GDR, 
several actions were taken, in particular in 1974 and in 
1981 . Since 1974 appeals had been placed in medical 








United Kingdom 13,000 236
Federal Republic of Germany 4,100 68
German Democratic Republic 335 21
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Only one year after launch the IfAr received mes-
sages about adverse reactions . In August 1985 a moth-
er applied Arupex® to herself and to both of her chil-
dren . Contrary to the instructions for use the mother 
used a swimming cap instead of a towel to cover the 
head . Two hours later the mother and her eleven year 
old daughter complained of dizziness, vomiting and 
disorders of speech . The five year old son even suffered 
from respiratory depression .27 
In November 1985 the IfAr was informed about 
another child suffering from headache and paleness af-
ter Arupex® had been applied correctly .28 Because of 
these incidents a meeting of IfAr representatives and 
the chief physician of a paediatric clinic in Potsdam 
who had reported these adverse reactions took place in 
the same month . As a result it was recommended that 
the lindane content be reduced from 1 .00 to 0 .33 per 
cent, and that the instructions for use be revised .29
These new instructions now advised the user to cov-
er the hair just with a towel, and in no case with a tight 
covering such as a swimming cap or plastic foil . More-
over, it was recommended that Arupex® be adminis-
tered only once and no longer twice, that it be applied 
for not more than 60 minutes, and that the application 
be repeated only after nine days . Any preventive appli-
cation was disapproved of . Finally it advised that babies 
should not be treated without the supervision of a phy-
sician .30
Against the background of the incidents depicted, 
the development of a drug containing permethrin as an 
alternative to Arupex® was demanded .31 Though the 
ZGA had already recommended the development of 
such a medicinal product in 1982, the pharmaceutical 
industry was not able to realize it until 1988 .32
Anti-diabetic agents in the 1970s
Unlike with Arupex®, in many cases the IfAr, the ZGA 
and the Ministry of Health had to rely on developments 
in other countries in order to draw conclusions for their 
own assessments of potential adverse drug reactions . In 
the late 1970s one of the issues the ZGA was concerned 
with was lactic acidosis, a severe metabolic disorder, 
which had been reported to be associated with the ad-
ministration of biguanides, a group of antidiabetic 
drugs which included phenformin and buformin . Bu-
formin, which had been launched in 1964, was the only 
biguanide available in the GDR . Additionally, the 
range of oral antidiabetic drugs available was limited to 
Maninil® and Orabet® . Both contained sulfonylureas; 
Maninil® contained glibenclamide and Orabet® con-
tained tolbutamide .33
In the Federal Republic of Germany the issue of 
lactic acidosis caused by biguanides was first discussed 
in December 1976 . As a consequence of these discus-
sions the indications of the biguanides were restricted .34 
The East German Ministry of Health reacted to this 
development by calling upon the ZGA to investigate 
the availability of diabetic drugs in the country .35 At its 
meeting in June 1977 the ZGA sub-committee recog-
nized that national differences in the medical care of 
diabetic patients were considerable .36 Since the 1950s a 
system had been established with the creation of spe-
cialist centres for diabetes where patients were attended 
to by experienced diabetic specialists . In all districts 
these care centres were set up as special departments in 
the so-called Polikliniken .37 
According to the ministerial guidelines for the ad-
vanced struggle against diabetes from 1973, all thera-
peutic measures including drug prescription lay in the 
hands of these centres .38 Likewise, the sub-committee 
noted the restricted indications that had already been 
implemented in therapy recommendations made in 
1974 . Accordingly, the administration of buformin 
had merely been recommended for overweight pa-
tients with type 2 diabetes .39 These recommendations 
were revised in the following months . In particular, 
the daily maximum dose was reduced from 400 to 
300mg of buformin hydrochloride . In addition, doc-
tors were advised that the prescription of insulin and 
oral antidiabetics was reserved to the diabetic special-
ists exclusively .40
In March 1978 the withdrawal of phenformin and 
buformin was recommended in the Federal Republic of 
Germany .41 After only a few days the East German 
ZGA sub-committee commented on this statement, 
and presented basically two alternatives . On the one 
hand, buformin could have remained included on the 
list of drugs available for the treatment of diabetes; but 
in this case the committee concluded that it would then 
be necessary to regulate its ever increasing consump-
tion . 
On the other hand, the deletion of buformin from 
the list was discussed . However, this option would 
have required a greater supply of Maninil® . For the 
production of this antidiabetic drug it would have 
been necessary to import raw materials from western 
countries, which would have caused considerable ex-
penditure of foreign currencies .42 In the end, the Min-
istry of Health decided against the deletion of bu-
formin, because the greater provision of insulin also 
had to be considered .43
Hormone pregnancy tests 1978
In contrast to its decision regarding the antidiabetic 
drugs, the Ministry of Health banned the use of hor-
mone pregnancy tests like Turignost® in the same year . 
The ban was made just a few weeks after the GDR me-
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dia had attacked the West German pharmaceutical 
company Schering AG,44 which had launched the hor-
mone pregnancy test Duogynon® in the 1950s . Duogy-
non®, marketed in the UK as Primodos®, came under 
suspicion of being teratogenic, and was therefore criti-
cized in the West German media in the 1970s .45 
The East German newspaper Sächsische Zeitung 
raised the issue too . Despite the fact that in the GDR 
similar tests had been used and that alternative immu-
nological tests had not sufficiently been available, the 
story was headlined ‘Nach Contergan vom Rhein jetzt 
Duogynon aus Westberlin: Schering gibt GIFT in den 
Mutterleib’ [‘After Contergan from the Rhine now Du-
ogynon from West-Berlin: Schering administers poison 
to the womb’] .46 As a result of this publicity doctors and 
pharmacists became irritated and contacted the IfAr .47 
The ban was the result . 
Analgesics in the 1980s
The analgesic, antispasmodic and antipyretic metami-
zole (dipyrone) became the subject of criticism in the 
Federal Republic of Germany in the 1980s because of 
serious adverse drug reactions such as agranulocytosis . 
As a result the ZGA chairman in the GDR warned the 
Minister of Health of the risk of a potential scandal 
similar to that in the case of Duogynon®/Turignost®, 
because in both countries metamizole was available 
without prescription . 
After metamizole became available on prescription 
only in the Federal Republic of Germany in 1987, the 
ZGA did not make that recommendation for the GDR, 
because metamizole was frequently used for self-medi-
cation and alternative medicinal products often con-
tained phenacetin which was frequently misused and 
assessed as harmful . Consequently, the ZGA demand-
ed that the pharmaceutical industry replace phenacetin 
with paracetamol . Even though the committee had al-
ready made that recommendation in 1983 it took six 
years to implement it .48
Beta blockers 1975
Besides the assessment of approved drugs, the ZGA 
also evaluated drugs which had not yet been approved 
in the GDR . These included the beta-1-selective 
blocking agent practolol, originally developed by the 
British chemical company Imperial Chemical Indus-
tries . It was marketed as Eraldin® in 1970 in the Unit-
ed Kingdom and as Dalzic® in the Federal Republic 
of Germany . Since 1974 reports on adverse drug re-
actions had increased in the UK after several months 
or years of application . Cases of eye and skin chang-
es such as psoriasis-like eruptions occurred, as well as 
otitis media, tinnitus, deafness and peritonitis .49 
Considering the adverse reactions, the distribution of 
Dalzic® was stopped in the Federal Republic of Ger-
many in 1975 . However, clinics were still expected to 
retain the product for use in ‘special cases’ in the fu-
ture .50 
At the same time in the GDR, practolol was still 
subject to clinical trials .51 Due to the reported adverse 
drug reactions the application for approval was with-
drawn and another clinical trial was not endorsed at the 
ZGA meeting at May 22, 1975 . In addition, the com-
mittee urged the manufacturer VEB Arzneimittelwerk 
Dresden to examine the beta-1-selective blocker talino-
lol in a follow-up study .52 In order to maintain the nov-
el beta-1-receptor blocker, the structure of practolol was 
modified in Dresden . 
Eventually, talinolol was selected from a variety of 
compounds .53 The ZGA suggested that the beta-recep-
tor blocker ought to be registered at least one year ear-
lier than practolol in order to support drugs original-
ly developed in the GDR .54 The registration was 
recommended on 30 January 1975 . As a result of the 
adverse drug reactions arising from practolol the com-
mittee had already demanded a follow-up study at that 
time .55
Conclusion
Efforts to control the range and availability of medici-
nal products in the German Democratic Republic were 
already in place in the Soviet occupation zone during 
the late 1940s . In this regard a special committee called 
Zentraler Gutachterausschuss für Arzneimittelverkehr 
(ZGA) became important . However, the poor econom-
ic situation, especially in the 1980s, was one reason for 
the pharmaceutical industry not being able to fulfil eve-
ry requirement made by the ZGA and the Ministry of 
Health . 
A second state institution, the Institut für Arznei-
mittelwesen (IfAr) later assumed responsibility for some 
aspects of the supply of medicinal products in the 
GDR . Amongst its responsibilities was the collection 
of reports of adverse drug reactions . Although several 
actions had been taken in the 1970s and 1980s, the 
number of reports remained low, so that the ZGA had 
to consider developments in other countries, in particu-
lar in the Federal Republic of Germany . 
Nevertheless, the examples – including the antidia-
betic drugs and analgesics available over the counter – 
discussed in this article demonstrate that the range of 
drugs available in the German Democratic Republic 
was taken into account as well .
Author’s address: Dr . Ariane Retzar, Wissenschaftliche 
Mitarbeiterin, Philipps-Universität Marburg, Institut 
78 PHARMACEUTICAL HISTORIAN  ·  2017  ·  Volume 47/4
https://doi.org/10.24355/dbbs.084-202007291108-0
für Geschichte der Pharmazie, Roter Graben 10, 35032 
Marburg, Germany .
Email: ariane .retzar@pharmazie .uni-marburg .de .
Endnotes and References
1 . Anon . Anordnung über die Regelung und Überwa-
chung des Verkehrs mit Arzneimitteln . Zentralverordnungsblatt, 
Teil I 1949: 766-767 .
2 . Anon . Erste Durchführungsbestimmung zum Arznei-
mittelgesetz . Gesetzblatt der DDR , Teil II 1964: 485-501, see 
487 .
3 . Gerecke, K . 25 Jahre Zentraler Gutachterausschuß für 
Arzneimittelverkehr . In Institut für Arzneimittelwesen (ed .) . 
Arzneimittel der Deutschen Demokratischen Republik. Arzneimit-
telwesen, Arzneimittelstandardisierung, Arzneimittelsortiment. 
Berlin: Verlag Volk und Gesundheit, 1975: 37-53 .
4 . Richter, J . Das Institut für Arzneimittelwesen . In 7b 
Direkt Apothekenservice AG (ed .) . 45 Jahre Pharmazie in 
Deutschland Ost. Fürstenfeldbruck: 7b Direkt Apothekenservice 
AG, 2007: 81-156 .
5 . Institut für Arzneimittelwesen (ed .) . Arzneimittelver-
zeichnis, 8. Ausgabe, Teil I . Berlin: Verlag Volk und Gesundheit, 
1969: inside front cover . For this topic see also Aagaard, L . et al . 
Pharmaceutical Production Problems Detected by Adverse Drug 
Reactions Report: A Documentary Study from the German 
Democratic Republic, 1982 to 1990 . Journal of Clinical Toxicol-
ogy 2012; 2(2): 1-10 and Retzar, A . Erfassung und Bewertung von 
unerwünschten Arzneimittelwirkungen. Ein Beitrag zur Arzneim-
ittelsicherheit in der DDR . Stuttgart: Wissenschaftliche Ver-
lagsgesellschaft, 2016 .
6 . Anon . Mitteilungen . Medicamentum 1969; 10(10): 319 .
7 . Institut für Arzneimittelwesen (Note 5) 1969: inside 
front cover .
8 . Institut für Arzneimittelwesen (ed .) . Arzneimittelver-
zeichnis, Ausgabe 1980, Teil I . Berlin: Verlag Volk und Gesund-
heit, 1979: 7 .
9 . Anon . Neues Meldeformular für die Spontanerfassung 
schädlicher Arzneimittelwirkungen . Informationen für Apothek-
en und Versorgungsdepots 1985; 2(12): 143-145 .
10 . Institut für Arzneimittelwesen (ed .) . Arzneimittelver-
zeichnis, Ausgabe 1986, Teil I. Berlin: Verlag Volk und Gesund-
heit, 1986: back cover .
11 . Wolski, M . Methodenkritische Untersuchung zur Gestal-
tung eines nationalen Systems der Ermittlung und Bewertung von 
Arzneimittelrisiken unter besonderer Berücksichtigung der Spon-
tanerfassung schädlicher Arzneimittelwirkungen. PhD disserta-
tion, Humboldt University Berlin, 1988: 170 . Nebenwirkungs-
meldungen 1987-1989, Bundesarchiv Berlin, DQ 116 / 283 . 
Nebenwirkungsmeldungen 1989/90, Bundesarchiv Berlin, DQ 
116 / 284 .
12 . Stapel, U . Die Arzneimittelgesetze 1961 und 1976. Stutt-
gart: Deutscher Apotheker Verlag, 1988: 559 .
13 . Wolski, M . (Note 11) 1988: 102 .
14 . Retzar, A . (Note 5) 2016: 192-193 .
15 . Anon . Schädliche Arzneimittelwirkungen bedürfen der 
wissenschaftlichen Erfassung und Auswertung . Das deutsche Ge-
sundheitswesen 1974; 29(27): VI .
16 . Anon . Schädliche Arzneimittelwirkungen bedürfen der 
wissenschaftlichen Erfassung und Auswertung . Medicamentum 
1975; 16(1): back cover .
17 . Anon . Schädliche Arzneimittelwirkungen bedürfen der 
wissenschaftlichen Erfassung und Auswertung . In Institut für 
Arzneimittelwesen (ed .) . Zentrale Therapie-Empfehlungen . Ber-
lin, 1974: loose leaf edition .
18 . Linke, W . and Hackenberger, F . Zentrale Therapieemp-
fehlungen – eine Möglichkeit zur Durchsetzung einer wissen-
schaftlich begründeten Therapie . Medicamentum 1979; 20(9): 
280-281 .
19 . Richter, J . et al . (eds .) . Arzneimittel- und Apothekenrecht 
der Deutschen Demokratischen Republik. Gesetzessammlung mit 
Kommentar, 9. Lieferung. Berlin: Akademie-Verlag, 1983: 
C051150 .
20 . Anon . Anweisung über den Umgang mit Arzneimitteln 
in Gesundheitseinrichtungen – Arzneimittelordnung . Verfügun-
gen und Mitteilungen des Ministeriums für Gesundheitswesen 1981: 
1-3, see 3 .
21 . Institut für Arzneimittelwesen (Note 10) 1986: back 
cover .
22 . Heydel, E . et al . Taschenbuch Arzneimittelsicherheit. 
Berlin: Verlag Volk und Gesundheit, 1983 . Heydel, E . et al . 
Taschenbuch Arzneimittelsicherheit. Berlin: Verlag Volk und Ge-
sundheit, 1986 .
23 . Anon . Dritte Durchführungsbestimmung zum Arznei-
mittelgesetz – Anwendung von Arzneimitteln in der Human-
medizin . Gesetzblatt der Deutschen Demokratischen Republik, Teil 
I 1986: 488-491, see 490-491 .
24 . Wolski, M . (Note 11) 1988: 188 .
25 . Institut für Arzneimittelwesen (Note 5) 1969: 19 .
26 . Anon . Arupex/VEB Ankerwerk Rudolstadt, 
Pharmazeutika Königsee . Informationen für Apotheken und Ver-
sorgungsdepots 1984; 1(1): 2 .
27 . Protokoll zur Beratung ‘Zwischenfälle bei der Läuse-
bekämpfung mit Arupex, Ankerwerk Rudolstadt‘ am 20 .11 .1985, 
Bundesarchiv Berlin, DQ 1 / 14507; Meldungen von schädli-
chen Arzneimittelwirkungen an das Institut für Arzneimittel-
wesen der DDR vom 19 .08 .1985, Bundesarchiv Berlin, DQ 116 
/ 130 .
28 .  Schreiben von Dr . Hübschmann und Dipl .-Med . 
Lehmann, Bezirkskrankenhaus Potsdam, Kinderklinik ‘Albert 
Schweitzer‘, an Dr . Müller, Institut für Arzneimittelwesen, vom 
14 .11 .1985, Bundesarchiv Berlin, DQ 116 / 130 .
29 . Protokoll zur Beratung ‘Zwischenfälle bei der Läuse-
bekämpfung mit Arupex, Ankerwerk Rudolstadt’ am 20 .11 .1985, 
Bundesarchiv Berlin, DQ 1 / 14507 .
30 . Anlage 2 der Gütevorschrift Nr . 61/86, bestätigt am 
18 .07 .1986, Gebrauchsanweisung Arupex®, Bundesarchiv Berlin, 
DQ 116 / 130 .
31 . Ergebnisprotokoll der Beratung Kopflausbekämpfungs-
mittel Permethrin am 15 .01 .1986, Bundesarchiv Berlin, DQ 1 / 
14507 . 
32 . Retzar, A . (Note 5) 2016: 241-242 .
33 . Institut für Arzneimittelwesen (ed .) . Arzneimittelver-
zeichnis, Ausgabe 1977, Teil I. Berlin: Verlag Volk und Gesund-
heit, 1977: 27 .
34 . Arzneimittelkommission der Deutschen Apotheker . 
Anwendung biguanidhaltiger Arzneimittel zur Diabetes-Behand-
lung . Pharmazeutische Zeitung 1977; 122(2): 66-67 .
35 . Schreiben von Dr . [Hans] Probst an Dr . [Klaus] Ger-
ecke vom 11 .05 .1977, Bundesarchiv Berlin, DQ 1 / 14472 . For 
the assessment of adverse reactions of buformin see also Retzar, 
A . and Friedrich, C . Zwischen Restriktion und Renaissance: 
Geschichte der Biguanide . Pharmakon 2013; 1(3): 204-213 .
36 . Protokoll der Sitzung des ZGA-Unterausschusses ‘Insu-
lin und orale Antidiabetika’ vom 03 .06 .1977, Bundesarchiv Ber-
lin, DQ 1 / 14471 .
 PHARMACEUTICAL HISTORIAN  ·  2017  ·  Volume 47/4 79
https://doi.org/10.24355/dbbs.084-202007291108-0
37 . Bibergeil, H . and Schliack, V . Die Betreuung der Dia-
betiker in der Deutschen Demokratischen Republik . Das 
deutsche Gesundheitswesen 1974; 29(40): 1891-1896 .
38 . Anon . Grundsätze zur Weiterentwicklung der Bekämp-
fung des Diabetes mellitus . Verfügungen und Mitteilungen des 
Ministeriums für Gesundheitswesen 1973: 137-139, see 138 .
39 . Bibergeil, H . et al . Empfehlungen für die Therapie des 
Diabetes mellitus und seiner Komplikationen . In Institut für 
Arzneimittelwesen (ed .) . Zentrale Therapie-Empfehlungen . Ber-
lin, 1974: loose leaf edition .
40 . Stellungnahme des Fachbeirats für Diabetes beim Mini-
sterium für Gesundheitswesen zum aktuellen Stand der Bigua-
nid-(Buformin-)Therapie vom 14 .10 .1977, Bundesarchiv Berlin, 
DQ 1 / 14472 .
41 . Arzneimittelkommission der Deutschen Apotheker . Be-
schluß des BGA zu biguanidhaltigen Arzneimitteln . 
Pharmazeutische Zeitung 1978; 123(10): 431-432 .
42 . Protokoll der ordentlichen Sitzung des ZGA-Unteraus-
schusses ‘Insulin und orale Antidiabetika‘ vom 07 .03 .1978, Bun-
desarchiv Berlin, DQ 1 / 14471 .
43 . Hausmitteilung von Dr . [Ulrich] Schneidewind an M1 
vom 04 .04 .1978, Bundesarchiv Berlin, DQ 1 / 14472 .
44 . Schreiben von Prof . Dr . [Ludwig] Mecklinger an die 
Bezirksärzte vom Oktober 1978, Bundesarchiv Berlin, DQ 116 
/ 1275 .
45 . For details see Retzar, A . (Note 5) 2016: 242-247 .
46 . Anon . Nach ‘Contergan’ vom Rhein jetzt ‘Duogynon’ 
aus Westberlin: Schering gibt GIFT in den Mutterleib . Sächsis-
che Zeitung 21 .09 .1978: 3 .
47 . Retzar, A . (Note 5) 2016: 248-249 .
48 . Retzar, A . (Note 5) 2016: 215-226 .
49 . Abraham, J . and Davis, C . Testing Times: The Emer-
gence of the Practolol Disaster and its Challenge to British Drug 
Regulation in the Modern Period . Social History of Medicine 
2006; 19(1): 127-147 .
50 . Arzneimittelkommission der Deutschen Ärzteschaft . 
Zweiter Warnhinweis zu Practolol . Deutsches Ärzteblatt 1975; 
72(13): 859 .
51 . Dück, K .-D ., Knappe, J . and Strube, G . Erste Behand-
lungsergebnisse mit dem Beta-Rezeptorenblocker Bonnecor® . 
Das deutsche Gesundheitswesen 1975; 30(20): 920-924 .
52 . Protokoll der 183 . Sitzung des ZGA, Sektion Human-
medizin am 22 .05 .1975, Bundesarchiv Berlin, DQ 1 / 26604 .
53 . For details see Retzar, A . (Note 5) 2016: 160f .
54 . Protokoll der 178 . Sitzung des ZGA, Sektion Human-
medizin am 20 .06 .1974 . Bundesarchiv Berlin, DQ 1 / 26604 .
55 . Protokoll der 181 . Sitzung des ZGA, Sektion Human-
medizin am 30 .01 .1975 . Bundesarchiv Berlin, DQ 1 / 26604 .
80 PHARMACEUTICAL HISTORIAN  ·  2017  ·  Volume 47/4
https://doi.org/10.24355/dbbs.084-202007291108-0
Further studies on some of the contents of 




Further studies have been done on the contents of two 
drawers (of three) in an Italian seventeenth century po-
made chest/cabinet . Two samples from the top drawer, 
known to be soft soaps from previous work, were chem-
ically analyzed to determine how they had been made . 
Unexpectedly, results show that they were made from 
a mixture of ruminant animal fat and a plant oil (prob-
ably olive oil) . Empty containers from the bottom draw-
er had the words written on their waxed paper covers 
transcribed, translated and investigated . There is evi-
dence that the chest was one of several gifts sent by the 
Grand Duke of Tuscany to Oliver Cromwell in 1657 .
Introduction
In history it is not unusual for new information to be 
found that alters our interpretation of an event or of a 
person’s actions . The ‘story’ can change over time as 
diaries, letters and other items are found (and if neces-
sary translated) to give new insights . However, it is un-
usual for the ‘story’ to change in analytical science . 
Sometimes several interpretations are possible of the 
collected data, and sometimes they result from new 
data from a different analytical technique . 
In this article I present new analytical chemistry 
data (and their interpretation) on the contents of two 
of the glass containers in the top drawer of an Italian 
seventeenth century pomade chest .1, 2, 3 It is said to have 
been one of several gifts sent to Oliver Cromwell by the 
Grand Duke of Tuscany in 1657 . This new data gives 
rise to some additions and amendments to previously 
published results .2 Also presented here are some tran-
scriptions and translations from the original hand-writ-
ten old Italian found on the wax paper coverings of 
some of the empty glass containers in the bottom draw-
er of the chest . There follows a discussion of their most 
likely original contents and uses .
The chest, its provenance and the people associated 
with it 
In May 1654, Ferdinando II de’ Medici (Figure 1), the 
Grand Duke of Tuscany (1610-1670) who ruled be-
tween 1621 and 1670, instructed his English agent to 
acquire a portrait of Oliver Cromwell (1599-1658), who 
was Lord Protector of England between 1653 and 1658 . 
By the end of the year a portrait had been purchased 
and delivered to him . Exactly which portrait he ac-
quired is unclear; it could have been the famous ‘warts 
and all’ one painted by Sir Peter Lely (1617-1680) (Fig-
ure 2) . Or it could possibly be the one reputedly done 
by Robert Walker (1599-1658) .4 However, this latter 
picture is sometimes attributed to Lely, and such a pic-
ture is now in the Uffizi Gallery in Florence . The more 
famous Lely picture is now to be seen in the Pitti Gal-
lery of Florence . 
There is evidence that in 1657 the Grand Duke sent 
various gifts to Oliver Cromwell, one of which is re-
puted to be the stone inlaid Florentine cabinet (or 
chest), along with its contents (Figure 3) currently on 
display in the Oliver Cromwell Museum in Hunting-
don, Cambridgeshire, UK . The cabinet’s dimensions 
are as follows: 41cm wide by 36cm deep and 29 .5 cm 
Figure 1. Ferdinando II de' Medici, Grand Duke of Tus-
cany
(Source: Wikimedia Commons)
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high . The cabinet has been independently inspected by 
furniture historians and assessed to be a Florentine ‘pi-
etra dura’ (literally ‘hard stone’) cabinet made in the 
period 1653-1658 .5 The contents of the cabinet’s small 
glass tubs and pots (some of which can be seen in the 
foreground of Figure 3) are believed to have been made 
up by the L’officina Farmaceutica di Santa Maria No-
vella in Florence prior to the cabinet being sent to Eng-
land .6
Samples and analytical methods and Results
The contents of the cabinet’s original glass tubs and pots 
were all removed and placed in modern glass air-tight 
containers about forty years ago . Four samples from the 
top drawer were previously analyzed and found to be 
soft potassium soaps, and it was suggested that they had 
been made from olive oil .2 Small amounts were also re-
moved from two containers of the middle drawer and 
were analyzed . These initial results indicated that each 
sample contained in varying amounts; sodium palmi-
tate, beeswax (and possibly some plant wax), and also 
cocoa butter and/or ruminant adipose fat .3
More data have recently been collected on these 
middle drawer samples, but have not yet been inter-
preted; this will be published in a later paper . Only 
empty containers are present in the bottom drawer, but 
most of these do have visible words, in Old Italian, writ-
ten on their waxed paper coverings . Very few of the 
containers in the top two drawers have any writing vis-
ible on their plain non-waxed parchment paper cover-
ings . A brief summary of relevant previously published 
analytical data will be presented in the Discussion sec-
tion which follows . 
For the top drawer samples two analytical tech-
niques were applied . These were Fatty Acid Methyl Es-
terification (FAME) combined with Gas Chromatog-
raphy-Mass Spectroscopy (GC-MS); and Gas 
Chromatography-Combustion-Isotope Ratios Mass 
Spectroscopy (GC-C-IRMS) . These were applied to 
two of the top drawer samples, those labeled TD 2 and 
TD 4 .7, 8 The results are summarized below, with some 
additional data given in an endnote .9
Figure 2. Oliver Cromwell, Lord Protector of England
(Source: Cromwell Museum©, Huntingdon, UK )
Figure 3. The Florentine cabinet and some containers
(Source: Cromwell Museum©, Huntingdon, UK) 
Results of the FAME GC-MS and GC-C-IRMS anal-
yses 
For sample TD 2, ten of the 20 compounds identified 
were saturated straight-chain carboxylic acids 
(C7/8/9/14/15/16/17/18/19/20, to a total presence of al-
most 87%) . Only two acids have percentage values 
greater than 5%; Palmitic acid (C16:0, 31 .9%) and 
Stearic acid (C18:0, 41 .0%) . Additionally there were: 
two dicarboxylic acids (C8/9, to a total of 2 .0% and 
where the C9:0 – Azelaic acid – is 1 .3%); four isomers 
of C18:1 (to a total of 7 .7%, where the isomer corre-
sponding to Oleic acid is present at 2 .6%); and four 
branched-chain saturated acids – one of C14:0 at 0 .5%, 
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one of C16:0 at 0 .5% and two of C17:0 to a total of 
2 .0% . 
For sample TD 4, nine of the 21 compounds iden-
tified were saturated straight-chain carboxylic acids 
(C7/8/9/14/15/16/17/18/20, to a total of almost 89%) . 
Only two acids have percentage values greater than 5%; 
Palmitic acid at 33 .5% and Stearic acid at 46 .2% . Ad-
ditionally there were: three dicarboxylic acids (C8/9/10, 
to a total of 2 .6% and where the C9:0 has the highest 
value, of 1 .7%); five isomers of C18:1 (to a total of 
6 .0%, where the isomer corresponding to Oleic acid is 
present at 1 .7%); one isomer of C18:2 (at 0 .4%); C14:1 
(at 0 .3%) and two branched-chain C17:0 (to a total of 
1 .4%) .
Table 1: Results of the GC-C-IRMS analyses
TD 2 Sample TD 4 Sample
δ13C16:0 –28 .58 ‰  
(per mille)
δ13C16:0 –28 .31 ‰  
(per mille)
δ13C18:0 –30 .41 ‰ δ13C18:0 –30 .25 ‰
∆ δ13(C18:0 – C16:0) 
–1 .83 ‰
∆ δ13(C18:0 – C16:0) 
–1 .94 ‰
The results of the GC-C-IRMS analyses are sum-
marized in Table 1 . The interpretation of these numbers 
will be presented in the Discussion section which fol-
lows below, which also includes translations of the Old 
Italian words found on some of the covering wax papers 
of the empty glass containers in the bottom drawer and 
a brief discussion of their original compositions and 
uses . 
Discussion
Contents of the top drawer sample containers 
In a previous publication four of these samples (TD 
2/4/5/12) were studied and found to have only one crys-
talline (soap) salt present–potassium oleate .2 This was 
done by comparing the low-angle/high d-spacing values 
from X-Ray Powder Diffraction (XRPD) data to frag-
mentary diffraction data in the published literature – to 
give a probable ‘match’ for this compound .10 
However now, from the above FAME GC-MS data 
on TD 2 and TD 4, it can be seen that as there is very 
little oleic acid and large, and roughly equal, amounts 
of palmitic and stearic acids present, then the crystal-
line soap salt seen by XRPD cannot be the oleate salt . 
A potassium soap salt is present, as shown by the previ-
ous publication’s Low Vacuum Scanning Electron Mi-
croscopy data (for elemental analysis showing a high 
percentage of potassium present) and Fourier Trans-
form Infra-Red Spectroscopy (showing the presence of 
a hydrated soap) data . The samples are soft solids (as 
expected for potassium soaps) and one sample (TD 4) 
had, on its original parchment paper cover, the words, 
in old Italian, ‘Saponetto di Fior’ Aranci’ – literally 
‘small soap with orange tree flowers’ (Figure 4) . In Re-
naissance Europe (between the fourteenth and seven-
teenth centuries) the word ‘Saponetto’, according to the 
Treccani Dictionary (the Italian equivalent of the Oxford 
English Dictionary), was a soap that was either solid or 
liquid, strongly scented and used for washing the hands 
and face and for perfuming small clothing items . Also, 
when some of this sample was mixed with a small 
amount of de-ionised water, an observable lather was 
obtained .2 
Figure 4. Sample TD 4 and its labeled paper cover
(Source: Cromwell Museum©,  Huntingdon, UK) 
Using recently published XRPD data on a range of 
crystalline potassium soap salts,11 and also using the 
predicted values for the observed (largest) d-spacings 
for soap mixtures given in a separate study,12 then for 
the (essentially) binary soap crystalline mixtures (where 
the percentage presence values of the palmitic and 
stearic acids are close to each other and much larger 
than for other acids present) in my samples, I have as 
predicted, d-spacing values that are intermediate be-
tween those of the potassium palmitate and stearate 
salts .
Were these soaps made using olive oil?
It was previously suggested that these soaps were made 
using olive oil .2 To determine if this is in fact correct 
the previously summarized FAME GC-MS and GC-
C-IRMS data will now be interpreted .  The FAME GC-
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MS data on samples TD 2 and 4 showed only the pres-
ence of a degraded fat or oil (though a mixture is also a 
possibility) . There is a small number of oxidation prod-
ucts – that is a few short-chain dicarboxylic acids and 
no oxo-/hydroxy-/dihydroxy- derivatives . The presence 
of both mono- and di- carboxylic C9:0 acids suggest an 
original larger amount of oleic acid (C18:1) .8 
The presence of palmitic (P, C16:0) and stearic (S, 
C18:0) acids in significant and similar amounts com-
bined with the presence of small amounts of: odd-num-
bered saturated acids (C15:0, C17:0 and C19:0), multi-
ple isomers of C18:1 and various branched-chain 
saturated acids (C14:0, C16:0 and C17:0) – are all in-
dicative of the presence of animal fat .8, 13, 14
The calculation of various fatty acid ratios can be 
done, and using various discriminatory values the type 
of fat/oil can be indicated . Such indications should be 
used with caution as exceptions (to the discriminatory 
values generally used) can occur, and complications can 
arise if a mixture is present . If possible these ratios 
should be combined with additional information .14 
The most well-known of these ratios is the palmitic 
acid/stearic acid ratio (P/S, C16:0/C18:0) . A cut-off val-
ue of 1 .3 is often used; where P/S > 1 .3 this suggests the 
presence of non-ruminant (usually taken to be porcine) 
fat; and if P/S < 1 .3 then ruminant (i .e . bovine or ovine) 
adipose fat is indicated . The ratios in this case are 0 .78 
for TD 2 and 0 .72 for TD 4, indicating a ruminant 
adipose fat for both samples .13, 14
A second fatty acid ratio is a combination of two 
ratios: stearic acid/palmitic acid (S/P) along with C17:0 
br . (branched-chain)/C18:0 . If S/P is > 0 .5 then terres-
trial animal fat is suggested; if S/P < 0 .5 then plant oil 
or marine animal fat is indicated . If C17:0 br ./C18:0 is 
< 0 .02 then non-ruminant fat is suggested, and if it is 
> 0 .02 then ruminant fat is indicated . In this case the 
values for TD 2 and TD 4 respectively are: S/P = 1 .28 
and 1 .38, and C17:0 br ./C18:0 = 0 .048 and 0 .030 . Ru-
minant fat is therefore indicated for both samples .15 
The last fatty acid ratio is (C15:0 + C17:0) / (C12:0 
+ C14:0 + C16:0 + C18:0) . When this ratio > 0 .04 then 
ruminant fat is suggested; if it is < 0 .04 then non-ru-
minant fat is indicated . The TD 2 and TD 4 values are 
0 .060 and 0 .041 respectively, once more indicating the 
presence of ruminant fat .16 Thus, overall from these 
three fatty acid ratios ruminant fat is indicated, and 
furthermore, from the P/S ratio, it can said that rumi-
nant adipose fat is indicated .
Supporting evidence from additional analytical data
Results from fatty acid ratios should be combined with 
other data if at all possible; these can include historical 
records (such as recipes) and additional analytical data . 
The analytical technique often used is GC-C-IRMS . 
Measurements from this technique, on an unknown 
fat/oil-containing residue, are compared to values from 
modern-day reference fats/oils and so the unknown fat/
oil can be identified . 
By measuring the carbon stable isotope (i .e . 13C vs . 
12C) ratios, usually expressed as δ13C values for the FAs 
(fatty acids) C16:0 and C18:0, it was found to be pos-
sible to distinguish fats/oils of different origins . Refer-
ence data, enclosed within confidence ellipses for each 
type of modern-day fat/oil studied, are placed on a plot 
of δ13C18:0 vs . δ13C16:0 . The number of ellipses have 
increased over time and there is now sometimes a de-
gree of overlap between some of the ellipses .8 
I have compared my data range9 to several such ref-
erence plots and found that it is mostly in-between two 
ellipses – those for ruminant adipose fat and C3 plant 
oils, where C3 is one of the three metabolic pathways 
for carbon fixation in photosynthesis of plants . There is 
a degree of overlap of my data with the reference rumi-
nant adipose fat ellipse (of about 30%), and whilst no 
actual reference data for a specific C3 plant oil directly 
overlaps with my data, the closest plant oil data is that 
for olive oil .17, 18 Thus, the above plot shows we have a 
mixture, which was used to make our soft soaps, of ru-
minant adipose fat and a plant oil (probably olive oil) . 
The ruminant fat is the larger component of the mix-
ture, with the (olive) oil being present in a smaller 
amount . To quantify the amounts of these components 
present will require future theoretical calculations and/
or experimental measurements on suitable mixtures of 
known composition .
Additionally, ∆δ13 (C18:0 – C16:0) can be plotted 
against δ13C16:0 . Three horizontal bands were gener-
ated using reference data and these are (with approx . 
numerical ranges given in brackets): the most negative 
∆δ13 values are for ruminant dairy fat (-6 to -3); less 
negative for ruminant adipose fat (-3 to -1) and mostly 
positive for pig adipose fat (-1 to +2) .8, 17 My average 
∆δ13 value is -1 .89 ‰ and is in the ruminant adipose 
fat band . One of the few publications which have placed 
their C3 plant oil GC-C-IRMS data on this type of plot 
found that for the six oils studied the ∆δ13 range was 
approximately -2 to +1, with most of the values being 
in the pig adipose fat range .17 
Supporting evidence from historical records 
A very old written recipe for soft soap – albeit in a very 
crude and impure form – has been found at Girsu 
(modern-day Tello, Iraq) . It has been dated to the third 
dynasty of Ur (c .2100 BC) . The recipe is the combina-
tion of oil (approximately one litre) and potash (approx-
imately 5 .5 litres); where the potash is assumed to be 
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the impure potassium carbonate in wood ash . It was 
used to de-grease and clean cloth .19
Almost two millennia later Pliny the Elder (23-79 
AD) gave another recipe for soft soap . He stated that it 
was first invented by the Gauls and Germanic tribes of 
Northern Europe and primarily used to dye and bleach 
their hair .2, 19, 20 The translation gives the recipe: 
‘Soap is the invention of the Gauls and this is used 
to redden the hair . It is made from fat and ashes – 
the best is beechwood ash and goat fat, the two com-
bined thick and clear . Many among the Germans use 
it, the men more than the women’ .20
It is unclear, for the above recipe, if the ashes men-
tioned were converted to impure caustic potash (i .e . 
potassium hydroxide) and then reacted with the goat 
fat to give a soft soap very similar to one made in the 
seventeenth century . However, in the Roman Empire 
of the second century AD, it is thought that such con-
version was being done to make soft soaps used for both 
clothes and body washing .2, 19, 20, 21 
The making of soap, often on a small scale by the 
formation of a craft guild, slowly spread throughout 
Europe . One of the first recorded such guilds was in 
Naples of the late sixth century AD . By c .700-800 AD 
soap-making was an established craft industry in Italy 
and Spain . The original Castile soft soap was said to be 
made at this time in Spain using olive oil, wood ashes 
and perfume . By the thirteenth century soap-making 
was established in Bristol, Coventry and London in 
England . Initially the manufactured soft soap was im-
ported, but by the 1500s the olive oil was imported to 
make such soap in England . It was used alone or com-
bined with tallow for making soft soaps at first, and 
later (from c .1700) increasingly for making hard bar 
soaps, which took longer to make, but were easier to 
handle and did not require tree ashes .2, 22, 23
Soft soap recipes in Italy before 1700
Information on soft soap recipes, using olive oil as an 
ingredient, in Italy before 1700 is sparse . In Savona of 
the 1500s olive oil was mixed with laurel berry or seed 
oil to make soap, but it is unclear if this is soft or hard 
bar soap . Given the time period it would be expected 
to be soft soap . Also, no specific information could be 
found for a soft soap recipe using olive oil and tallow . 
However, it would be expected that any given country 
making soap at this time would probably largely use 
what was readily available within the country, and Ita-
ly usually had a plentiful supply of olive oil and tallow 
(i .e . bovine/ovine adipose fat) . Thus a recipe such as 
ours, where the olive oil has been diluted with tallow, 
could have been a common occurrence rather than the 
result of lack of olive oil because of a bad olive harvest . 
Such a recipe could have been the result of experimen-
tation to give a soft soap of desirable qualities, such as 
increased stability to reduce it becoming rancid and 
having an acceptably (small) degree of skin irritation 
when used on human skin .24 
Over time soaps have been variously used medici-
nally . For example, they have been used externally as a 
treatment for skin diseases, burns and sores . They have 
been taken internally for relief from ‘gravel’ (urinary 
stones), as a mild antacid or laxative, and Castile soap 
pills were taken for the relief of dysentery . Soap has 
been used as a non-toxic filler of pills in general, and as 
a pseudo-active ingredient in a whole range of quack 
medicines .2, 23, 25, 26 
Some examples of specific medicinal uses of soft 
soaps are: ‘liquid’ soap (taken to be soft soap) is listed 
as an ingredient in several recipes for the treatment for 
burns in the early seventeenth century;27 as a recipe for 
an enema (an unspecified soft soap diluted twenty times 
with warm water) in Theobald’s 1752 New Compendi-
ous Dispensatory;28 and today a dilute aqueous solution 
of potassium oleate has been found to be a very effec-
tive pesticide against cockroaches .29 
Figure 5. Sample BD 4 and its labeled waxed paper 
cover
(Source: Cromwell Museum©, Huntingdon, UK)
Contents of the bottom drawer sample containers 
Ten of the thirteen empty glass containers (labeled 
BD 1 to BD 13 by the Museum) in the bottom drawer 
of the chest have Old Italian writing on their wax paper 
coverings (see Figure 5 for one example, BD 4) . My cur-
rent best transcriptions and translations into English of 
these hand-written words are as follows: 
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BD 2, BD 5 and BD 9 reveal the words ‘Manteca 
(abbreviated to ‘Mj’ or ‘Mjca’ ) di Gelsomini’, which 
translates as ‘Ointment (or butter) of Jasmine” . BD 1, 
BD 7 and BD 12 disclose the words ‘Manteca (abbrevi-
ated as before, or even omitted altogether for BD 1) di 
Melangoli’, which translates as ‘Ointment of Bitter Or-
anges’ . BD 3, BD 4, BD 10 and BD 13 shows ‘Manteca 
(where this word, written in full, is only present for 
BD 4) di Caceia’, which I believe best translates as 
‘Ointment of game’ (i .e . the fat of a hunted game ani-
mal, such as wild deer, pig or boar) . 
The BD pots were empty of contents when the 
chest was loaned to the Cromwell Museum over four 
decades ago . There are two possible reasons why they 
were empty: firstly, all the contents in all the pots were 
rapidly used by descendants of Oliver Cromwell; or 
secondly, and perhaps more likely, the game fat used 
in their manufacture rapidly became rancid, and so 
gave rise to offensive smells that resulted in the pots 
being emptied .
Jasmine extract, or its essential oil,1 is used as a top-
ical medicine (usually as a small amount in a base ma-
terial), for the relief of dry, sensitive or irritated skin . It 
is also used for muscle sprains and spasms, and as a skin 
massage agent it induces relaxation .30 Bitter orange ex-
tract/oil has various medicinal uses, where it can be in-
gested (heavily diluted) or applied topically (as for jas-
mine above) . Used topically it is relaxing and sedative, 
and so is used to encourage sleep . However, it can some-
times cause skin irritation and should be used heavily 
diluted and used with care .31 
Wild animal (i .e . game) fat was known and proba-
bly used topically in Tuscany of the seventeenth cen-
tury – perhaps mixed with a coloring agent and a herb-
al or inorganic active ingredient . Domesticated pig’s fat 
was used in skin ointments – for example it was found 
in two of four recently analyzed skin ointment residues, 
dated to the sixteenth and seventeenth centuries, from 
labeled containers in the Aboca Museum (Arezzo, Ita-
ly) .32 Additional, non-medicinal, uses of scented oint-
ments/pomades will be mentioned later . 
Scented ointments/pomades of the seventeenth cen-
tury were often made by cold (enfleurage) or hot (mac-
eration) absorption of fragrant molecules into a base 
material of fat/oil .1 A base material of the period, such 
as ‘Leaf of Hogs-fat’ (i .e . lard), would have been repeat-
edly washed to remove as much of its odor as possible 
before fresh flowers of jasmine would be used to cover 
the base when it was laid out in trays, for the enfleurage 
process .33 Bitter orange extract can be simply obtained 
by the method of ‘expression’ (that is by squeezing, here 
of the inside fleshy part of the peel of the fruit) and then 
adding as required to a de-odorized fat/oil .
Recipes for scented ointments/pomades
Many recipes for scented ointments or pomades existed 
in the past, and some examples are: a pomatum ‘to re-
fresh the complexion’ made of lard, sweet almond oil 
and apples’ parts; ‘pomatum for the lips’ made using 
butter, Virgin wax (i .e . fresh beeswax), black grapes and 
orange-flower water; various ‘floral waters’ which con-
tain very small amounts of dissolved odorant material 
from rose, lavender or orange extracts and which were 
used for food flavoring or even as a beverage; and a po-
made recipe is mentioned by Dioscorides (c . 40-90 AD) 
in his De Materia Medica, which he called Iasmelaion 
and was made from sesame oil and the white flowers of 
jasmine – being recommended for use on the whole 
body after bathing ‘for those that want warmth and re-
laxation’ .33, 34, 35  
The various aroma molecules are often very volatile 
and so quickly evaporate/degrade under the action of 
heat, light, moisture and oxygen . Thus all that usually 
remains in an old residue of a scented ointment/pomade 
is the degraded base material .35 A rare example of a pos-
sible remnant of a plant part being found was in the 
analyses of the amorphous residues found in seven Ro-
man glass unguentaria . They were dated to between 
first century BC and first century AD, and were exca-
vated from a Roman villa in the ancient town of Op-
lontis (about 20 km south east of Naples, Italy) . Apart 
from beeswax and pine resin found in all the contain-
ers, the presence of a plant-waxy-lipid was also suggest-
ed . The authors suggested that this last material was 
from the wax of the plant part(s) (possibly a leaf or flow-
er) used in maceration or enfleurage to make the origi-
nal scented skin ointments .36  
Additional non-medicinal uses of scented oint-
ments/pomades over time have included: anointing the 
living and embalming the dead; to create a pleasant 
aroma at feasts/social gatherings; for individual use af-
ter bathing either at home or after exercise at the gym-
nasium; to scent clothes/gloves/leather-work; to keep 
‘evil spirits’/insects/plague at bay and to cover up skin 
defects of old age or caused by disease .34, 35  
Conclusions
The new data from two analytical techniques (FAME 
GC-MS and GC-C-IRMS) have shown that, for the 
top drawer samples, a new interpretation of their origins 
is required . These samples are still potassium (soft) 
soaps, but are now shown to have been made from a 
mixture of ruminant adipose fat (i .e . bovine or ovine 
fat) and a smaller amount of a plant oil (probably olive 
oil) . This recipe could be one commonly used for soft 
soap-making in Tuscany of the seventeenth century, or 
it could be one specially devised for these samples to 
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give soaps that would not readily turn rancid and that 
could be used on the hands and face with minimal skin 
irritation . The latter may or may not now be true, but 
the samples are not now obviously rancid . One of our 
samples studied (TD 4) was definitely scented and 
some/all of the other top drawer samples may well have 
also been (differently) scented originally . 
The bottom drawer samples were probably intended 
as scented pomades/pomatums for the hair or as scent-
ed ointments/unguents/balms for the skin . As to how 
medically efficacious they would have been when ap-
plied to the hair/skin is unclear, but they would at least 
have covered/protected a skin ailment and would have 
smelt pleasant initially . However, this probably did not 
last as the game fat used as their base material would 
have become rancid eventually, resulting in all the pots 
being emptied of their contents . 
The changes in origin of the top drawer samples 
shows that any given explanation must often in reality 
be limited and considered to be, at least to a degree, as 
preliminary . This is here caused by: degradation effects 
over centuries, the complexities of interpreting some-
times apparently contradictory analytical data and by 
the paucity of direct documentary evidence of the rec-
ipes used to make the original samples . The process to-
wards a better understanding of these samples can 
therefore also be described as an iterative one . This pro-
cess is greatly helped by a multi-analytical approach 
and from having access to relevant historical informa-
tion . 
Oliver Cromwell and the Grand Duke of Tuscany
The only information we currently have of Cromwell’s 
reaction to being given various gifts, including ‘oils and 
essences’ (assumed to refer to the contents of this po-
made chest), from the Grand Duke of Tuscany is from 
a report written by Francesco Giavarina (the Venetian 
Resident in England) to Venice on 25 May 1657 . The 
translation of the relevant part of his report is given be-
low:37
‘Salvetti, the Florentine Resident, has recently pre-
sented the Protector in the name of the Grand Duke 
with a dozen butts of different wines, expressly sent 
from Tuscany, with a quantity of other fancy food 
stuffs, oils and essences which his Highness has made 
and distilled . Cromwell is gratified although the 
wine has much deteriorated on the voyage . But the 
Protector has no great taste for anything and he is 
not disposed to regard favourably presents of this 
character . One of his physicians has stated that he 
has not the courage to put such liquors to his lips . 
He is possibly afraid that they will be bitter, being 
fearful of his own shadow, so to speak, and living in 
constant apprehension of everything, for he trusts 
no one’ .
Whilst some of this may well be an exaggeration, it 
is most likely broadly accurate . 
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Fudge’s Firewater was the nickname given to a cough 
medicine that was made and sold from the mid-1950s 
at the pharmacy of Kenneth Fudge in the small market 
town of Bridport in Dorset in south west England . Its 
proper name was Fudge’s Mentholated Honey Syrup, a 
local variant of Gee’s Linctus . Its main ingredients were 
camphorated tincture of opium, oxymel of squill and 
tolu syrup, to which menthol had been added . Despite 
ownership of the formula and the place of sale chang-
ing several times over the next 50 years, the product is 
a rare example of a nostrum that survived into the 
twenty-first century . 
Introduction
Until 2006, in the market town of Bridport in the south 
west of England, the local population had access to a 
remarkable cough medicine that really seemed to work . 
The medicine was Fudge’s Mentholated Honey Syrup, 
or, as the locals christened it, ‘Fudge’s Firewater’ . The 
story begins in the 1950s when a Mr Ken Fudge in Dor-
set started to make and sell his own nostrums, at a time 
when every pharmacy had their own range of cough 
syrups, indigestion mixtures and throat pastilles . Most 
nostrums ceased to be available after implementation 
of the 1968 Medicines Act, but ‘Fudge’s Firewater’ sur-
vived into the twenty-first century .
Many local people had fond memories of the prod-
uct, and Fudge’s Firewater soon entered local folklore . 
Its content, preparation and uses can thus readily be 
ascertained from surviving sources, and people’s expe-
riences of it have been captured by means of a ‘Memo-
ries of Fudges Firewater’ call on Facebook .1 This short 
article tells the story of this potent mixture, what it 
contained, how it was used and why it is no longer avail-
able, using material from a variety of sources .2 
Mr Fudge and his pharmacy
Kenneth Charles Fudge was born and brought up in 
Blandford, a market town in north Dorset, a county in 
the south west of England . He trained as a pharmacist 
and qualified in 1933, having undertaken his appren-
ticeship in Blandford . He appears to have spent the 
early part of his career in London, since in 1955 he was 
living in Edgware . However, around that time he re-
turned to his native Dorset, moving from London to 
Bridport, another market town, not far from the south 
coast . He opened a pharmacy in West Allington, next 
door to the shop of Balsons, who were Britain’s oldest 
family butchers, having been established in 1515 . 
Figure 1. Mr Fudge’s Pharmacy in the late 1950s, when 
the road was flooded. Mr Fudge is seen standing in the shop 
doorway with Donald Balson from the next door butchers’ 
shop in front (Source: Photo kindly supplied by Richard 
Balson)
Fudge’s was a traditional pharmacy that sold the 
usual range of toiletries, cosmetics and photographic 
requisites, in addition to having a thriving trade in the 
sale of over the counter medicines and a busy prescrip-
tion dispensing service . A Kodak sign was displayed 
prominently above the door, and attention to the phar-
macy was drawn by a magnificent sign on which the 
word ‘chemist’ appeared below a mortar and pestle and 
which hung above the shop window . The only downside 
was that the street outside was subject to occasional 
flooding .
The origins of Fudge’s Firewater
In the mid-1950s, many pharmacists devised their own 
remedies, often to secret recipes, and Mr Fudge was no 
exception . He made several nostrums, the name given 
to those remedies produced and sold in a single phar-
macy, but the most popular and enduring was his Men-
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tholated Honey Syrup (known locally as Fudge’s Fire-
water) . 
Table 1: Key dates in the story of Fudge’s Firewater
Year Event
1950s Mr Kenneth Fudge opens his pharmacy at 7 
West Allington, Bridport and begins produc-
tion of Mentholated Honey Syrup (‘Fudge’s 
Firewater’) . 
1973 Mr Fudge retires, and the recipe for Firewater 
transfers to Mr Joe Sparrow at his 24 East 
Street Pharmacy .
1975 Mr Kevin Morrish takes over the East Street 
Pharmacy, together with Fudge’s Firewater .
1998 Mr Morrish retires and sells the business 
which is then acquired by the Lifestyle Phar-
macy Group .
2001 Moss Chemists Ltd acquires the East Street 
Pharmacy . Mr David Conroy is the manager 
until 2005 .
2006 The owners Moss Pharmacy, subsequently re-
branded as Alliance Pharmacy, cease produc-




Fudge’s Firewater continues to be available in 
Weymouth, at the St John’s Pharmacy of Mr 
Dipan Shah, but only with a private prescrip-
tion .
2009 Fudge’s Firewater ceases to be available .
Mr Fudge’s medicine was a dark brown syrupy liq-
uid made by mixing menthol crystals and a little fudge 
flavouring into Gee’s Linctus, itself an old-fashioned 
cough remedy dating from the Victorian era . Gee’s 
Linctus, otherwise known as Compound Squill Linc-
tus, or Opiate Squill Linctus of the British Pharmaceu-
tical Codex (BPC), contains several potentially active 
ingredients . 
Gee’s Linctus consisted of equal volumes of cam-
phorated opium tincture, oxymel of squill, and tolu 
syrup . The tincture of opium was an alcoholic extract 
of opium, the resin derived from opium poppies . The 
main active ingredient in opium is morphine, a sub-
stance with an established effect on cough3, but also a 
well-known drug of abuse . Because the linctus con-
tained morphine but only at low levels (<0 .02%), it was 
categorised as a schedule 5 controlled drug (Misuse of 
Drugs Regulations 2001)) and could be supplied 
through a registered pharmacy without a prescription . 
Squill, a plant extract, was another potentially active 
component in the linctus that, paradoxically, encour-
ages coughing and mucus removal . The medicine also 
contained alcohol at similar levels to a fortified wine, 
and this may have contributed to the Firewater experi-
ence . 
Mr Fudge’s masterstroke was to boost the effects of 
the Gee’s Linctus by adding menthol, a remedy used for 
many years to help with symptoms of coughs and 
colds4 . The menthol may also have acted as an oral an-
aesthetic, helping with sore throats, and it may have 
relieved nasal congestion . 
Although cough medicines cannot alter the course 
of viral infections they may help the patient feel better . 
Fudge’s medicine attacked symptoms in several ways . 
It was the menthol, however, that made the potion so 
memorable, justifying the Firewater nickname and es-
tablishing a shared experience among those who used 
it, believed in it and benefited from it . 
As a result of its capacity to help patients feel better 
it became extremely popular and a very successful nos-
trum . It is clear that it was made in very substantial 
quantities . People travelled long distances to purchase 
the medicine . Holidaymakers reportedly often went 
home with extensive supplies, and during some winters 
as many as 250 bottles of Fudge’s Firewater were sold 
each week at the East Street Pharmacy .5
Following the introduction of the 1968 Medicines 
Act, many nostrums and proprietary medicines disap-
peared because of the new regulations on licensing . 
Fudge’s Firewater persisted into the 21st century because 
it was exempt from licensing (see section 10 of the reg-
ulations) being a nostrum made in a registered phar-
macy for sale in that pharmacy with no advertising . 
The recommended uses of Fudge’s Firewater
Fudge’s Firewater was an old-style cough medicine rec-
ommended for common winter ailments: coughs, colds, 
influenza, loss of voice, hoarseness, sore throat and ca-
tarrh . The dose was one teaspoonful [5 ml] every four 
hours, but the label warned ominously that each spoon-
ful should be ‘taken very slowly’ . It was sold from the 
pharmacy over-the-counter without prescription, but 
strictly under the control of the pharmacist . 
Fudge’s Firewater was immensely popular, and 
many people have told the author how much they trust-
ed it to help their symptoms . Typical comments were 
‘a brilliant cough mixture, couldn’t beat it’, ‘an amaz-
ing medicine for coughs and sore throats’, ‘never bought 
anything else’, and ‘please, if there is a God, bring back 
Fudge’s Firewater’ .  
The medicine had a formidable reputation amongst 
its users . Comments included ‘it nearly blew your head 
off, but by golly it did the trick’ and Gail Reichter re-
called that ‘the menthol did take your breath away’ .6 
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Some of these effects may have been caused by the men-
thol accumulating at the surface of the medicine when 
it had not been fully mixed . Some experienced rather 
more serious symptoms . Margery Hookings recalled 
that 
‘It tasted like red diesel mixed with the finest bran-
dy-lovely . And as it shifted your fever you halluci-
nated at the same time . I remember being tucked up 
in bed with flu in my damp, rented cottage in the 
middle of nowhere and peeping out of the covers to 
see a demon-like face made up of lots of dots, zig-
zagging all over the woodchip wallpaper . One min-
ute it was smiling, the next scowling, possibly at the 
interior design . Scary but interesting .’7 
It was not the easiest medicine to take, and some 
patients commented on this . ‘It was a trial to take, but 
you knew it would make you better’ and several people 
spoke of ‘the Fudge’s shudder’ . As Mr Fudge himself 
said: ‘Some do swear by it, some do swear at it’ . 
Even now, more than a decade after the medicine 
was discontinued in its home town, the mere mention 
of the Fudge’s name evokes a warm wave of nostalgia 
and longing in many Bridport people .
Unconventional uses of Fudge’s Firewater
Its growing reputation led to its use for a number of less 
conventional purposes . The medicine was a voice-saver 
for some professional singers, and the author has heard 
about one well-known entertainer who would regular-
ly send a friend to buy Firewater from Mr Morrish to 
help lubricate her vocal cords . Another fan of the prod-
uct was Marco Rossi . He recalled that
‘In the mid-to-late 1990s I was the guitarist/vocalist 
in a band called Stocky Lamaar, who essentially ran 
on Fudge’s . At the time, bassist/vocalist Al and my-
self played a whole heap of gigs in smog bound, pre-
smoking ban pubs around Dorset with a variety of 
different but uniformly noisy line-ups, which inevi-
tably meant that we were yelling ourselves hoarse on 
an almost nightly basis . We tried everything to rem-
edy this (apart from giving up smoking!) and I even 
went to a throat specialist at one point .
At this juncture, like a living advert tagline, our pal 
Pete said ‘have you tried this?’ and produced a bot-
tle of Fudge’s…and that proved to be the miracle 
cure . Nothing I’ve tried before or since has ever cut 
to the chase with such brute fervour . It felt as though 
it just punched straight through the throat strata of 
detritus and fag ash, leaving you suddenly able to 
breath properly, and sing without sounding like 
Madge from Neighbours at a Bonnie Tyler tribute 
karaoke night . After that a bottle of Fudge’s became 
as essential a component of my guitar case as spare 
strings and leads . Anyone who remembers Stocky 
Lamaar from the time will remember that Al and I 
would have a bottle apiece resting on each of the PA 
speakers .’8
Abuse of Fudge’s Firewater 
Non-prescription medicines such as Gee’s linctus, and 
variations of it such as Fudge’s Firewater, have been 
abused by people trying to access even the small 
amounts of morphine they contain9 . Gee’s linctus, for 
example, is reported to induce a ‘lovely euphoria and 
dreaminess’9, but only if the user is prepared to drink 
50ml or more of the medicine at a time . Local pharma-
cists were aware of the problem and tried to control it: 
Mr Morrish monitored all sales of Fudge’s Firewater 
personally, and Mr Conroy, the manager in the early 
twenty-first century, restricted sales to one bottle per 
person, with a signature . 
The end of Fudge’s Firewater
Fudge himself retired from his pharmacy in 1973, and 
the recipe for Firewater transferred to Mr Joe Sparrow 
at his pharmacy at 24 East Street, Bridport . That phar-
macy was itself taken over in 1975 by Mr Kevin Mor-
rish, and Fudge’s Firewater continued to be made and 
Figure 2. A bottle of Fudge’s Mentholated Honey Syrup 
(Fudge’s Firewater) (Source: Photo kindly supplied Emily 
Hicks, Bridport Museum)
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sold under his supervision . Mr Morrish was the longest 
serving “custodian” of Fudge’s Firewater until he retired 
in 1998 . The business and the Firewater were then ac-
quired by the Lifestyle Pharmacy Group, who managed 
them until 2001 when the East Street Pharmacy was 
acquired by Moss Chemists Ltd; Mr David Conroy was 
its manager until 2005, and he continued to make and 
supply Fudge’s Firewater . 
Gee’s linctus itself gradually fell out of favour as a 
cough medicine because of the problem of abuse . Find-
ing commercial sources of the linctus became more dif-
ficult, and temporary interruptions to the availability 
of Fudge’s Firewater occurred early in the twenty-first 
century . Then, in January 2006, a notice appeared on 
the window of Bridport’s East Street Pharmacy (owned 
by Moss/Alliance) announcing that the medicine would 
be discontinued owing to ‘problems with the supply of 
ingredients’ . That was the official line, but the author 
suspects that this was not the full story . Towards the 
end of 2005, there had been a change in the pharmacy 
regulations10 whereby extemporaneously prepared med-
icines or nostrums containing Schedule 5 controlled 
drugs became prescription only medicines . Fudge’s 
Firewater, with its small amounts of morphine, was af-
fected by this change . It could no longer be sold over 
the counter and patients wanting the medicine would 
need a private prescription . Perhaps Moss/Alliance 
judged that this would seriously weaken sales and so 
decided to discontinue the medicine . 
That was not quite the end however, because in the 
same year, Fudge’s Firewater began to be sold by Mr 
Dipan Shah of the St John’s Pharmacy in Weymouth, 
Dorset, about 20 miles south east of Bridport . He con-
tinued to make and supply a modified version of the 
medicine for the next three years . However, the result 
of the change in pharmacy regulations (see above) 
meant that people needed to persuade their doctor to 
issue a private prescription if they wanted it . 
Not surprisingly the need for a private prescription, 
and the cost entailed, severely affected sales, and cou-
pled with increasingly stringent regulations for mixing 
medicines in pharmacies, production finally ceased in 
2009 . For all these reasons, Fudge’s Firewater is very 
unlikely ever to reappear . 
Conclusion 
Fudge’s Firewater served Bridport well for 50 years . Al-
though the medicine is now just a memory it is an im-
portant part of Bridport’s history and one deserving of 
being preserved . It also has an important place in the 
history of British pharmacy . At the very time Fudge’s 
Firewater was introduced many nostrums were begin-
ning to disappear, following the introduction of the 
National Health Service in 1948, the expansion of pro-
prietary medicines in the post-war period, and the 
growth of advertising in both magazines and on televi-
sion . 
Fudge’s Firewater is a rare example of a nostrum 
that survived into the twenty-first century . Further-
more, ownership of the recipe changed hands several 
times, the pharmacy where it was made and sold also 
changed hands on a number of occasions, and the prod-
uct continued even when the home pharmacy was in 
corporate ownership . Although in the end the recipe 
moved to a pharmacy in a different town, the demise 
of Fudge’s Firewater was the result of changes in phar-
macy regulations . 
Chemist’s nostrums are however still very much 
with us . The current regulations are published by the 
General Pharmaceutical Council in their Guidance for 
Registered Pharmacies Preparing Unlicensed Medicines 
(May 2014) . This states that ‘an unlicensed medicine 
that is prepared with the intention of selling it over the 
counter (one that is not a prescription-only medicine) 
is often called a ‘Chemist’s Nostrum .’11
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S H O R T  C O M M U N I C A T I O N
Cataloguing nature’s ‘library’:  




Generally viewed as a quaint, if puzzling, relic of the 
folk medical tradition, the Doctrine of Signatures and 
wider concepts of ‘sympathetic magic’ have informed 
selection patterns of natural medicines the world over . 
Associations between form and perceived medical value 
are idiosyncratic and culture specific . Briefly considered 
here are the factors that led to the development of a 
Doctrine of Signatures in the western tradition and 
what lessons it might impart when re-considered as an 
evolving series of ideas, rather than as a single doctrine .
Introduction
Faced with a multitude of unfamiliar and often danger-
ous plants that potentially held the keys to life and 
death, our ancestors needed ways to map and distin-
guish the helpful and harmful from the merely ineffec-
tual . One such way was to ascribe meaning to an ob-
ject’s shape, colour, location, smell or taste–seeking 
‘clues’ from these characteristics to indicate likely me-
dicinal purpose . 
For example, a plant resembling a lung (e .g . Pulmo-
naria officinalis L .) could be used to treat respiratory 
illness; red coloured plants (e .g . Vinca rosea L .) might 
be used to cure blood conditions; plants found near a 
river (e .g . Salix alba L .) could be beneficial in the treat-
ment of water-borne diseases . At the same time, sweet 
smelling (e .g . Acorus spp .) or bitter tasting plants (e .g . 
Momordica charantia L .) could be used to combat dis-
eases attributed to excessive bitterness (e .g . Kidney or 
Spleen disorders) or excessive sweetness (e .g . Diabetes) .
By finding similarities, patterns or signatures would 
emerge which could guide foragers and be passed into 
collective knowledge . Some even believed that plants 
spoke to them in hallucenogenic rituals (e .g . Ayahuasca) 
conveying secrets of their curative powers . 
Even animal parts and fossils were believed to pos-
sess healing properties that could be inferred from their 
outward appearance . Traditions as diverse as the Scan-
dinavian and the Native American record the use of Elk’s 
hoof as a remedy for ‘falling sickness’ (epilepsy) based 
on the Elk’s behavior of using its hoof to relieve itself 
from ‘vertigo’; the kidney shaped Jew’s Stone (Lapis ju-
daicus) which appears in Discorides’ De Materia Medica 
became a widely accepted cure for kidney stones . Over 
time, such ‘sympathetic magic’ would develop into rec-
ognizable medical systems such as Ayurveda and Unani 
and, in Western belief, into a ‘Doctrine’ of Signatures .
Cataloguing Nature’s ‘Library’
The earliest humans most probably derived information 
about plants from observing animals . Their proximity 
to and total reliance on their surroundings for nourish-
ment and medicine made it important that they could 
recognize signs of sickness and cure .
Zoopharmacognosy, the branch of science that 
seeks to understand animals’ self-medication, particu-
larly in the primate kingdom, has identified ‘strong sim-
ilarities’ in plant selection criteria between humans and 
chimpanzees .1
Notable is the shared use of rough leaves of certain 
Ficus species for the alleviation of pain associated with 
intestinal parasites . 
Selection criteria such as leaf texture, smell and taste 
have no doubt contributed to recognition of medicinal 
attributes and are, in certain ways, easier to identify 
than perceived physical resemblance to an organ .2 
However, these qualities are still subject to a wide spec-
trum of interpretation . 
How can perceptual and often esoteric impressions 
be objectively assessed? The answer may be, simply, that 
they cannot be studied bio-scientifically .3 Calling the 
Doctrine of Signatures ‘largely untestable’ Bennett, 
nevertheless, attempted a meta-analysis of botanical no-
menclature, looking at the descriptive suffix cordata 
(heart) to investigate whether this suffix corresponded 
to instances of reported cardiac therapeutic use . Using 
a sample of some 80 plant binomials he found there to 
be no significant correlation . However, the attempt to 
link what are known to be subjective descriptions to 
medicinal use can only paint a partial picture at best . 
Bennett concluded, among other things, that signatures 
acted as a mnemonic (memory aiding) device and 
should be regarded as ‘post hoc attributions rather than 
a priori clues’ to plant use .
I would suggest, with the necessity for communica-
tion over generations, signatures represent something 
more systematized than mere memory aids . Unable to 
document their pharmacopoeia, pre-literate societies 
learned to ‘read’ plants and these signatures evolved to 
function as ‘catalogue numbers’ in a natural ‘library’ .
How these ‘catalogue numbers’ were determined 
and assigned would, of course, vary - according to time, 
place and culture . For example, Pulmonaria officinalis 
L ., (lungwort), present in the northern United States, 
popular in Europe as a respiratory medicine and astrin-
gent, has no recorded medicinal use in North America . 
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In contrast, Scutellaria lateriflora L., (skullcap), a native 
of North America, known to be anti-convulsive and 
sedative in the European pharmacopeia has no equiva-
lent Native American medicinal use .4, 5 
Religion and Reformation
The ‘Doctrine’ of Signatures itself is, according to the 
American Anthropologist Daniel E . Moerman, a ‘Eu-
ropean’ idea . Porter (2006) believes that the Doctrine 
of Signatures ‘evolved gradually over the centuries’ .6 
Dyer (1889) wrote that the Doctrine of Signatures was 
‘a development of the much older notion of a real con-
nection between object and image’ .7 Duffin (2008) 
states that the Doctrine of Signatures’ roots are ‘firmly 
based on Aristotelian principles’ .8
(Genesis 30:14-16) where the anthropomorphic man-
drake (Figure 1) appears as an aphrodisiac and cure for 
impotence . The concept re-surfaces in Franciscan Friar 
Albertus Magnus’ De Mineralibus (c . 1260) and the 
first natural history encyclopedia, Hortus Sanitatis 
(1484) .
In the febrile climate of Reformation-era Europe, 
the Doctrine of Signatures remained something in 
which Christians could still agree . The writings of reli-
gious mystics, such as Jakob Böhme (1575-1624) con-
cerning cosmic signatures, would foreshadow the ‘new 
age’ worldview with its emphasis on the intrinsic unity 
of nature . Although the term signature implicitly sug-
gests an author and Creator, Böhme’s ideas, in particu-
lar, are closer to the Eastern ones of Hinduism and Bud-
dhism with their concepts of prana and qi - a ‘life force’ 
permeating everyone and everything .
Figure 1. Illustration of mandrake from a fifteenth cen-
tury Northern Italian herbal (author unknown)
(Source: Schoenberg Institute for Manuscript Studies at 
University of Pennsylvania Libraries)
In many respects the Doctrine of Signatures fits 
more comfortably into the realm of religion rather than 
science . Some of the earliest recorded references to the 
Doctrine of Signatures are found in the Old Testament 
Figure 2. Plants of the Asteracae family; one of multiple 
plates in della Porta’s Phytognomica (1588)
(Source: The Wellcome Library)
In 1588 the Italian polymath Giambattista della 
Porta (1535-1615) published the influential Phytogno-
monica which bridged the gulf between animism and 
rationalism . With its systematically juxtaposed images 
of body and plant parts (Figure 2) Phytognomonica dis-
plays evidence of a proto-scientific method .9 Indeed, for 
della Porta, true Natural Magick (as opposed to sor-
cery), was ‘nothing else but the survey of the whole 
course of nature’ .10
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A Curious Paradox
At its core, the Doctrine of Signatures presents a pro-
found conundrum . Hippocrates (460-370 BC) codified 
the prevailing medical opinion of his time with the ob-
servation: similia similibus curentur (by similar things 
are the sick made healthy); yet, a parallel, but seeming-
ly diametrically opposed, notion of contraria contrariis 
remedium (opposites cure opposites) found its expres-
sion in the later Galenic model . Both incorporated rem-
edies based on a Doctrine of Signatures-like rationale 
and this led to the formation of two distinct branches 
of homeopathic and antipathic medical practice . 
So, how do we reconcile these two linked but ap-
parently contradictory practices? I would argue that 
clues can be found in the much earlier Vedic concept 
of nirdvandva (cf . Carl Jung) or the transcending of op-
posites; the ‘oneness’ of creation rendering distinctions 
and, therefore, opposites obsolete .11 
Such ‘harmonic’ thinking, as reflected in the yin 
and yang of Chinese Taoism, was ultimately displaced 
in the West by dualism, which sought to construct dis-
crete opposing categories of things and ideas . Similia 
similibus curentur nevertheless survived as the founda-
tion for Samuel Hahnemman’s (1755-1843) Law of 
Similars, which underpins modern Homeopathy .12
A Doctrine in Decline
Over time, the Doctrine of Signatures became unable 
to hold the multiplicity of ideas within it . As early as 
the sixteenth century Dodoens (1517-1585), the famed 
Flemish Physician and Herbalist, branded the Doctrine 
of Signatures ‘so changeable and uncertain that it seems 
absolutely unworthy of acceptance’ . Berdoe (1836-
1916), writing in 1888-whilst elsewhere lauding Para-
celsus (1493-1541) as the ‘Luther’ of medicine and 
chemical science, labelled his Doctrine of Signatures as 
‘very curious and most absurd’ .13 By the twentieth cen-
tury ‘faith’ in the Doctrine of Signatures had become 
the marginal preserve of homeopaths, herbalists and 
spiritualists . 
To its detriment, herbalism at its most reactionary 
has continued to promote the Doctrine of Signatures 
unquestioningly even when demonstrably harmful . For 
example, Aristolochia clematitis L . (birthwort) - selected 
for its supposed resemblance to the womb and birth ca-
nal and used historically for the treatment of women in 
childbirth - has in recent years been found to contain 
highly nephrotoxic and oncogenic aristolochic acid .14
Conclusion
Despite Western medicine’s rejection of the Doctrine of 
Signatures as animistic; superstitious; magical or even 
dangerous echoes of it persist in tradition-based medical 
systems (e.g. Traditional Chinese Medicine or TCM) 
which are of growing popular interest in the West and are, 
increasingly, the focus of serious ethno pharmacological 
studies which demonstrate the integrity of traditional 
healing categories and the superior reliability of ethno-
pharmacologically based drug leads . 15,16,17
In the same way that attempts to justify the Doc-
trine of Signatures have been labelled as examples of 
post hoc attribution, our evaluation - of a doctrine - rath-
er than of the disparate ideas which it contains could 
be seen in a similar light; a fundamental misunder-
standing clouded by history .
Perhaps, it is now time we stopped viewing the Doc-
trine of Signatures as a doctrine at all, but rather a series 
of interwoven, but distinct, ethnomedical concepts 
which, given a more sympathetic interpretation, could 
pass the insight of previous generations into our hands . 
Stripped of dogma, the Doctrine of Signatures speaks 
a proto-scientific truth–that a closer reading of our nat-
ural ‘literature’ might lead us to a more dynamic and 
fruitful relationship with the content of nature’s ‘li-
brary’ .
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150 years on: Joseph Lister and ‘The Anti-
septic Principle in the Practice of Surgery’
Ursula Lang
Abstract
It is 150 years since Joseph Lister published his seminal 
paper entitled ‘On the Antiseptic Principle in the Prac-
tice of Surgery .’ This short communication summarizes 
the background to this paper, and concludes that Lister 
fully deserves the title ‘father of modern antisepsis .’ 
Zusammenfassung
Vor 150 Jahren publizierte Joseph Lister seinen weg-
weisenden Aufsatz zur Anwendung antiseptischer Ver-
fahren in der Chirurgie . Diese kurze Darstellung fasst 
die Beweggründe zusammen, die Lister zu seiner Pub-
likation veranlassten und folgert daraus, dass Lister den 
Titel ‘Vater der modernen Antispesis’ völlig zurecht ver-
dient .
Lister’s paper in the British Medical Journal
On 21 September 1867 the British surgeon Joseph 
Lister (1827-1912) published a paper entitled ‘On the 
Antiseptic Principle in the Practice of Surgery’ in the 
British Medical Journal.1 It rapidly attracted the atten-
tion of numerous physicians .2 He introduced his 
ground-breaking essay with the following words: 
‘In the course of an extended investigation into the 
nature of inflammation, and the healthy and morbid 
conditions of the blood in relation to it, I arrived 
several years ago at the conclusion that the essential 
cause of suppuration in wounds is decomposition, 
brought about by influence of the atmosphere upon 
blood or serum retained within them, and, in the 
case of contused wounds, upon portions of tissue 
destroyed by the violence of the injury’ .
Lister was influenced by the researches of the French 
chemist Louis Pasteur (1822-1895) who had demon-
strated that putrefaction was not caused by oxygen or 
any gases, but by minute vital organisms suspended in 
the air .3 He was persuaded that ‘materials capable of de-
stroying the life of the floating particles could avoid decom-
position in the injured parts’. He expounded the use of 
carbolic acid as an antiseptic substance of great effec-
tiveness: 
‘The material which I have employed is carbolic or 
phenic acid, a volatile organic compound which ap-
pears to exercise a peculiarly destructive influence 
upon low forms of life, and hence is the most pow-
erful antiseptic with which we are at present ac-
quainted .’ 
Use of carbolic acid
Lister used carbolic acid in cases of compound fractures 
that formerly had often resulted in inflammation and 
eventually amputations: 
‘In conducting the treatment, the first object must 
be the destruction of any septic germs which may 
have been introduced into the wound, either at the 
moment of the accident or during the time which 
has since elapsed’ .
He advocated ‘the application of a piece of lint dipped 
in the acid, overlapping the sound skin to some extent and 
covered with a tin cap, which was daily raised in order to 
touch the surface of the lint with the antiseptic.’ This pro-
cedure should, he declared, prevent the entrance of sep-
tic germs into the wound . The antiseptic treatment had 
to be continued ‘during the first few days after the acci-
dent, when the acid originally applied has been washed 
out or dissipated by absorption and evaporation’. 
Lister referenced his publications in the Lancet in 
March and April 1867, and specified an improved pro-Figure 1. Joseph Lister (1827-1912)
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cedure by using antiseptic paste composed of carbonate 
of lime, mixed with a solution of carbolic acid in boiled 
linseed oil . Accordingly, the firm putty served as a res-
ervoir for the carbolic acid which was diluted thereby 
and was less irritating to the skin . Lister noted that car-
bolic acid itself could induce inflammatory suppuration 
of the surface of the skin by a process of chemical stim-
ulation . However, on the contrary, ‘decomposing sub-
stances’ were ‘self-propagating and self-aggravating poi-
sons’ that spread from the surface into recesses and 
blood’ .
tions, my wards […] have completely changed their 
character; so that during the last nine months not a 
single instance of pyaemia, hospital gangrene or ery-
sipelas has occurred in them . As there appears to be 
no doubt regarding the cause of this change, the im-
portance of the fact can hardly be exaggerated .’
In the following years many antiseptic substances 
with less toxicity and better compatibility were tested 
by innumerable surgeons . But the honour of the title 
Figure 2. Part of first page of ‘on the Antiseptic Principle in the Practice of Surgery,’ 1867
 Lister furthermore described the successful anti-
septic treatment of abscesses, contused and lacerated 
wounds and recommended improved methods of ap-
plying ligatures . Additionally, during the performance 
of an operation, a solution of carbolic acid in twenty 
parts of water should destroy ‘any septic germs that may 
fall upon the wound’ . 
Conclusion
Lister finished his essay with a remarkable and self-con-
fident statement: 
‘But since the antiseptic treatment has been brought 
into full operation, and wounds and abscesses no 
longer poison the atmosphere with putrid exhala-
‘father of modern antisepsis,’ the man who saved thou-
sands of lives, is rightly due to Joseph Lister .
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Van gildekast tot schoenendoos:  
Nederlandse simpliciaverzamelingen
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Venster op farmaciehistorie published on behalf of the 
Kring voor de Geschiedenis van de Pharmacie in Ben-
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pharmacy guilds, their assistants, and later on the ex-
amining bodies that tested and certificated their knowl-
edge; they were also prized by individual doctors, sur-
geons and midwives . While the pharmacopoeia was in 
a state of flux, such collections acted as reference mate-
rial until the recommendations of the national pharma-
copoeia had stabilised . They also helped the medical 
professional to distinguish between authentic and 
fraudulent medical ingredients . 
From an analysis of simplicia cabinets as advertised 
in various types of sales literature – advertisements, auc-
tion catalogues, etc . – from the 17th century onwards, 
the authors discovered that descriptions tended to focus 
on the quality of the box itself, the type of wood from 
which it was constructed, and the number of trays and 
cells for holding the medicinal simples themselves . They 
also found, perhaps unsurprisingly, that the cabinets 
were most commonly owned by doctors, pharmacists, 
surgeons and master midwives, although they were also 
found in the collections (naturalienkabinet) of a range 
of non-medical personnel .  These latter examples might 
often contain non-pharmaceutical objects of naturalia 
– geological, zoological and herbal specimens . Various 
College and institutional inventories give an indication 
as to the subsequent loss of many cabinets . Indeed, the 
authors conclude that the survivals (probably around 
4%) represent only the ‘tip of the iceberg’ in compari-
son to the number of cabinets that were once in circu-
lation . 
Johannes Brosterhuysen (1596-1650), a student at 
Leiden, wrote to Constantine Huygens (1608-1687), 
giving advice as to what simples should be included in 
a materia medica cabinet, based upon his own collec-
tion . Slightly later (1662) a simplicia cabinet was deliv-
ered to the Pharmaceutical College in the Hague; it re-
mained in use until the second half of the nineteenth 
century .
The heyday of simplicia cabinet production seems 
to have been during the eighteenth and nineteenth cen-
turies, with literally hundreds being offered for sale in 
the Netherlands . The design and architecture of the 
cabinet itself were extremely diverse with the number 
of trays ranging from 6 to 100 .  Contents do not seem 
to have been standardised; most simples were kept un-
packaged in their requisite trays, but later cabinets 
might include vials or glass slides . From 1890 onwards, 
the component simples were increasingly stored in 
sealed glass tubes and other containers supplied by the 
industry, rather than open trays . This meant that elab-
orate storage cabinets became progressively less neces-
sary and represented an un-necessary expense; materials 
packaged in specially designed Bakelite, plastic or glass 
Reviewed by Christopher J . Duffin
One gets the impression that materia medica or ‘sim-
plicia’ cabinets (i .e . collections of medicinal simples) are 
rare survivals of pharmaceutical material culture . This 
book, whose title could be rendered in English as ‘From 
guild cabinet to shoe box: Dutch simplicia Collections’ 
indicates that, at least in the Netherlands, they are well 
represented, and the authors present an extremely use-
ful survey of surviving collections .
In the Introduction, the authors explain how col-
lections of simples were necessary for the members of 
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containers could be stored in a box on the shelf – hence 
the reference to ‘shoe box’ in the title of the book .
The authors conclude that, while older materia 
medica cabinets are known from England and else-
where, the possession of a simplicia cabinet by an indi-
vidual for anything other than teaching is somewhat 
unique to the Netherlands, and something of an expres-
sion of the Dutch obsession, from the seventeenth cen-
tury onwards, for collecting material culture .
The bulk of the volume consists of a descriptive cat-
alogue of 54 surviving simplicia cabinets, the oldest dat-
ed to 1660, classified according to packaging materials: 
A, open or sealed boxes; B, sealed glass tubes, bottles or 
jars; C, paper sachets with transparent windows, pots or 
plastic tubes and boxes; D, glass pots, bottles and the like; 
E, others . Each cabinet is fully described with details of 
its current location, size, date of production, owner (if 
known), and history with occasional comments on the 
contents . Most entries are presented as a double page 
spread with good quality colour illustrations of both the 
cabinet itself, and representatives of the associated draw-
ers and their contents . Also, the text is supported with a 
comprehensive bibliography . The book is nicely printed 
on high quality glossy paper in A4 format . 
Publications on materia medica cabinets are very 
sparse and – clearly a labour of love by the authors – 
this volume provides a welcome survey of Dutch sur-
vivals . Worth the cover price for the illustrations alone, 
this book fills a gap in the literature, and will be of par-
ticular interest to those interested in the history of phar-
macy and the development of the materia medica .  
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